The molecular alteration of primary glioblastoma is mainly due to the amplification and overexpression of EGFR, while the molecular alteration of secondary glioblastoma is predominantly due to the mutation of TP53 [18–20]. This evidence concerns the gene EGFR and glioblastoma.